Robin Lesley

7.6k total citations · 4 hit papers
25 papers, 3.8k citations indexed

About

Robin Lesley is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robin Lesley has authored 25 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robin Lesley's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Robin Lesley is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Robin Lesley collaborates with scholars based in United States, France and Australia. Robin Lesley's co-authors include Christopher D.C. Allen, K. Mark Ansel, Jason G. Cyster, Satish Menon, D Rennick, Michael W. Leach, Jason G. Cyster, Nicole M. Haynes, Nigel Killeen and Ying Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Robin Lesley

24 papers receiving 3.8k citations

Hit Papers

IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pa... 2001 2026 2009 2017 2001 2004 2007 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
    2001 930 citations Madeline Fort, Jeanne Cheung et al. Immunity profile →
  2. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5
    2004 569 citations Christopher D.C. Allen, K. Mark Ansel et al. Nature Immunology profile →
  3. Role of CXCR5 and CCR7 in Follicular Th Cell Positioning and Appearance of a Programmed Cell Death Gene-1High Germinal Center-Associated Subpopulation
    2007 529 citations Nicole M. Haynes, Christopher D.C. Allen et al. The Journal of Immunology profile →
  4. Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma
    2020 233 citations Johannes Duell, Gerhard Zugmaier et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Lesley United States 14 2.6k 699 666 576 426 25 3.8k
David M. Lee United States 26 2.7k 1.0× 472 0.7× 574 0.9× 905 1.6× 258 0.6× 32 4.0k
Rachel Ettinger United States 32 4.3k 1.7× 831 1.2× 304 0.5× 1.4k 2.4× 256 0.6× 53 5.9k
Motoko Y. Kimura Japan 32 4.7k 1.8× 1.1k 1.5× 598 0.9× 1.2k 2.0× 248 0.6× 71 6.0k
Miriam Wittmann United Kingdom 42 2.7k 1.0× 406 0.6× 638 1.0× 810 1.4× 148 0.3× 114 4.4k
Parris R. Burd United States 26 2.4k 0.9× 822 1.2× 672 1.0× 943 1.6× 461 1.1× 34 4.0k
Tanya N. Mayadas United States 31 2.2k 0.8× 458 0.7× 359 0.5× 1.5k 2.6× 258 0.6× 45 4.8k
Dominic Picarella United States 22 2.2k 0.8× 635 0.9× 429 0.6× 528 0.9× 413 1.0× 35 3.2k
Renu Jain United States 22 2.0k 0.8× 445 0.6× 255 0.4× 604 1.0× 254 0.6× 33 3.0k
Roberta Pelanda United States 35 3.2k 1.3× 774 1.1× 180 0.3× 1.5k 2.6× 255 0.6× 84 4.9k
Cong‐Qiu Chu United States 27 1.7k 0.7× 742 1.1× 158 0.2× 709 1.2× 177 0.4× 69 3.8k

Countries citing papers authored by Robin Lesley

Since Specialization
Citations

This map shows the geographic impact of Robin Lesley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Lesley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Lesley more than expected).

Fields of papers citing papers by Robin Lesley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Lesley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Lesley. The network helps show where Robin Lesley may publish in the future.

Co-authorship network of co-authors of Robin Lesley

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Lesley. A scholar is included among the top collaborators of Robin Lesley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Lesley. Robin Lesley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Strati, Paolo, Richy Agajanian, Izidore S. Lossos, et al.. (2024). Acalabrutinib in combination with rituximab and lenalidomide in patients with relapsed or refractory follicular lymphoma: Results of the phase 1b open‐label study ( ACE ‐ LY ‐003). British Journal of Haematology. 206(3). 887–898. 2 indexed citations
4.
Dreyling, Martin, Jiřı́ Mayer, David Belada, et al.. (2024). High-Risk Subgroups and MRD: An Updated Analysis of the Phase 3 ECHO Trial of Acalabrutinib with Bendamustine/Rituximab in Previously Untreated Mantle Cell Lymphoma. Blood. 144(Supplement 1). 1626–1626. 2 indexed citations
5.
Zhu, Xu, César Pichardo‐Almarza, Kevin Smart, et al.. (2024). Exposure-Response Analysis and Quantitative Systems Pharmacology Modeling for Optimal RP2D Selection of AZD0486 in Follicular Lymphoma Patients. Blood. 144(Supplement 1). 2794–2794. 2 indexed citations
6.
Nair, Ranjit, Ryan Jacobs, Sumana Devata, et al.. (2023). HIGH COMPLETE RESPONSE RATE WITH TNB‐486, A NOVEL CD19XCD3 T‐CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY. Hematological Oncology. 41(S2). 127–129. 1 indexed citations
7.
Jacobs, Ryan, Ranjit Nair, Seok‐Goo Cho, et al.. (2023). S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY. HemaSphere. 7(S3). e60614fc–e60614fc. 1 indexed citations
8.
9.
10.
Einsele, Hermann, Johannes Duell, Gerhard Zugmaier, et al.. (2019). The anti-BCMA Bispecific T-cell Engager (BiTE®) Molecule AMG 420 Induced MRD-Negative Complete Responses in R/R Multiple Myeloma in a FIH study. Clinical Lymphoma Myeloma & Leukemia. 19(10). e18–e19. 1 indexed citations
11.
Topp, Max S., Johannes Duell, Gerhard Zugmaier, et al.. (2019). Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunotherapy, in R/R multiple myeloma (MM) patients: Updated results of a first-in-human (FIH) phase I dose escalation study.. Journal of Clinical Oncology. 37(15_suppl). 8007–8007. 44 indexed citations
12.
Lesley, Robin & Lalita Ramakrishnan. (2008). Insights into early mycobacterial pathogenesis from the zebrafish. Current Opinion in Microbiology. 11(3). 277–283. 67 indexed citations
13.
Haynes, Nicole M., Christopher D.C. Allen, Robin Lesley, et al.. (2007). Role of CXCR5 and CCR7 in Follicular Th Cell Positioning and Appearance of a Programmed Cell Death Gene-1High Germinal Center-Associated Subpopulation. The Journal of Immunology. 179(8). 5099–5108. 529 indexed citations breakdown →
14.
Lesley, Robin, Lisa M. Kelly, Ying Xu, & Jason G. Cyster. (2006). Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. Proceedings of the National Academy of Sciences. 103(28). 10717–10722. 76 indexed citations
15.
Allen, Christopher D.C., K. Mark Ansel, Caroline M. R. Low, et al.. (2004). Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nature Immunology. 5(9). 943–952. 569 indexed citations breakdown →
16.
Lesley, Robin, Ying Xu, Susan L. Kalled, et al.. (2004). Reduced Competitiveness of Autoantigen-Engaged B Cells due to Increased Dependence on BAFF. Immunity. 20(4). 441–453. 445 indexed citations
17.
Fort, Madeline, Robin Lesley, Natalie J. Davidson, et al.. (2001). IL-4 Exacerbates Disease in a Th1 Cell Transfer Model of Colitis. The Journal of Immunology. 166(4). 2793–2800. 69 indexed citations
18.
Fort, Madeline, Jeanne Cheung, David Yen, et al.. (2001). IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo. Immunity. 15(6). 985–995. 930 indexed citations breakdown →
19.
Davidson, Natalie J., S Hudak, Robin Lesley, et al.. (1998). IL-12, But Not IFN-γ, Plays a Major Role in Sustaining the Chronic Phase of Colitis in IL-10-Deficient Mice. The Journal of Immunology. 161(6). 3143–3149. 172 indexed citations
20.
Davidson, Natalie J., S Hudak, Robin Lesley, et al.. (1998). IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.. PubMed. 161(6). 3143–9. 208 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David M. Lee Breakdown of academic impact, for papers by Rachel Ettinger Breakdown of academic impact, for papers by Motoko Y. Kimura Breakdown of academic impact, for papers by Miriam Wittmann Breakdown of academic impact, for papers by Parris R. Burd Breakdown of academic impact, for papers by Tanya N. Mayadas Breakdown of academic impact, for papers by Dominic Picarella Breakdown of academic impact, for papers by Renu Jain Breakdown of academic impact, for papers by Roberta Pelanda Breakdown of academic impact, for papers by Cong‐Qiu Chu
Rankless by CCL
2026